Maria Celeridad

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “A cellular target engagement assay for the characterization of SHP2 (PTPN11) phosphatase inhibitors”.

A cellular target engagement assay for the characterization of SHP2 (PTPN11) phosphatase inhibitors

Journal of Biological Chemistry(2020)10.1074/jbc.ra119.010838

N/A

1.1DataRank · unranked

25 citations

Lester J. Lambert, Douglas J. Sheffler, Laurent J. S. De Backer, Raveendra-Panickar Dhanya, Maria Celeridad +8 more

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Journal of Visualized Experiments(2020)10.3791/61457

N/A

0DataRank · unranked

4 citations

Celeste Romero, Douglas J. Sheffler, Maria Celeridad, Nicholas D. P. Cosford, Lutz Tautz +1 more

Inhibitors of the Hippo Pathway Kinases STK3/MST2 and STK4/MST1 Have Utility for the Treatment of Acute Myeloid Leukemia

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00804

N/A

0DataRank · unranked

34 citations

A. Chaikuad, Nicole A. Bakas, Allison S. Limpert, Lester J. Lambert, Douglas J. Sheffler +11 more

Development of a Robust High-Throughput Screening Platform for Inhibitors of the Striatal-Enriched Tyrosine Phosphatase (STEP)

International Journal of Molecular Sciences(2021)10.3390/ijms22094417

N/A

0DataRank · unranked

15 citations

Stefan Grotegut, Maria Celeridad, Palak Gosalia, Laurent JS De Backer, Andrey A. Bobkov +8 more

Discovery of novel furanylbenzamide inhibitors that target oncogenic tyrosine phosphatase SHP2 in leukemia cells

Journal of Biological Chemistry(2021)10.1016/j.jbc.2021.101477

N/A

0DataRank · unranked

12 citations

Darren Finlay, Fabiana Izidro Layng, Lester J. Lambert, Maria Celeridad, Ming Zhao +16 more

Novel potent azetidine-based compounds irreversibly inhibit Stat3 activation and induce antitumor response against human breast tumor growth in vivo

Cancer Letters(2022)10.1016/j.canlet.2022.215613

N/A

0DataRank · unranked

18 citations

Yinsong Zhu, Christine Brotherton‐Pleiss, Wen‐Zhen Fu, Nagendra Verma, Jasmine Chen +17 more

Synthesis and Characterization of ULK1/2 Kinase Inhibitors that Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.05.674519

N/A

0DataRank · unranked

2 citations

Huiyu Ren, Nicole A. Bakas, Dhanya Panickar, Lester J. Lambert, Maria Celeridad +16 more

Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo

Cell Reports Medicine(2020)10.1016/j.xcrm.2020.100037

N/A

0DataRank · unranked

63 citations

Matthew D. Marsden, Peter Teriete, Alex J. Portillo, Dominik Heimann, Jocelyn T. Kim +10 more

ULK1/2 Inhibitors that Degrade ATG13 Effectively Target KRAS-Mutant Cancers

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.14.682402

N/A

0DataRank · unranked

0 citations

Huiyu Ren, Sonja N. Brun, Fabiana Izidro Layng, Dhanya Panickar, Lester J. Lambert +10 more